The Food and Drug Administration on Thursday approved Gilead Sciences’ antiviral drug remdesivir as a treatment for the coronavirus.
In May, the FDA granted the drug an emergency use authorization, allowing hospitals and doctors to use it on patients hospitalized with the disease even though the medication had not been…